Abstract:Aim: We aimed to systematically examine the effects of enzymatic activity of 38 human CYP2C9 alleles and 21 human CYP3A4 alleles, including wild-type CYP2C9.1 and CYP3A4.1, which contain the 24 CYP2C9 novel alleles (*36*60) and 6 CYP3A4 novel alleles (*28-*34) newly found in the Chinese population, on sildenafil metabolism through in vitro experiment.Methods: The recombinant cytochrome P450 alleles protein of CYP2C9 and CYP3A4 expressed in insect baculovirus expression system were reacted with 10-500 mu M sildenafil for 30 minutes at 37 degrees C, and the reaction was terminated by cooling to -80 degrees C immediately. Next, we used ultra-performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) detection system to detect sildenafil and its active metabolite N-desmethyl sildenafil.Results: The intrinsic clearance (Vmax/Km) values of most CYP2C9 variants were significantly altered when compared with the wild-type CYP2C9*1, with most of these variants exhibiting either reduced Vmax and/or increased Km values. Four alleles (CYP2C9*11, *14, *31, *49) exhibited no markedly decreased relative clearance (1-fold). The relative clearance of the remaining thirty-three variants exhibited decrease in different levels, ranging from 1.81% to 88.42%. For the CYP3A4 metabolic pathway, when compared with the wild-type CYP3A4*1, the relative clearance values of four variants (CYP3A4*3, *10, *14 and *I3357) showed significantly higher relative clearance (130.7-134.9%), while five variants (CYP3A4*2, *5, *24, *L22Vand *F1131) exhibited sharply reduced relative clearance values (1.80-74.25%), and the remaining nine allelic variants showed no statistical difference. In addition, the kinetic parameters of two CYP3A4 variants (CYP3A4*17 and CYP3A4*30) could not be detected, due to the defect of the CYP3A4 gene.Conclusion: These findings were the first evaluation of all these infrequent CYP2C9 and CYP3A4 alleles for sildenafil metabolism; when treating people who carry these CYP2C9 and CYP3A4 variants, there should be more focus on the relation of dose intensity, side effects and therapeutic efficacy when administering sildenafil The study will provide fundamental data on effect of CYP2C9 and CYP3A4 allelic variation on sildenafil metabolism for further clinical research.

Functional Characterization of Wild-Type and 24 Cyp2d6 Allelic Variants on Gefitinib Metabolism in Vitro

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

In Vitro Functional Assessment of 22 Newly Identified CYP2D6 Allelic Variants in the Chinese Population.

Functional Characterization of 22 Novel Cyp2d6 Variants for the Metabolism of Tamoxifen

Discovery and Enzyme Kinetic Characterization of Novel CYP2D6 Variants

In Vitro Functional Analysis of 24 Novel Cyp2c19 Variants Recently Found in the Chinese Han Population

Functional Characterization of Cyp2d6 Novel Allelic Variants Identified in the Chinese Han Population

Pharmacogenetic Determinants of Gefitinib Trough Concentration in Patients with Non-Small Cell Lung Cancer.

In Vitro Functional Characterization of 37 CYP2C9 Allelic Isoforms Found in Chinese Han Population.

Characterization of 15 CYP2J2 variants identified in the Chinese Han population on the metabolism of ebastine and terfenadine in vitro

In Vitro and in Vivo Characterization of 13 CYP2C9 Allelic Variants Found in Chinese Han Population

Functional Characterization of Five CYP2C8 Variants and Prediction of CYP2C8 Genotype-Dependent Effects on in Vitro and in Vivo Drug-Drug Interactions.

Association Analysis of Cyp2a6 Genotypes and Haplotypes with 5-Fluorouracil Formation from Tegafur in Human Liver Microsomes

Functional Characterization Of 22 Cyp3a4 Protein Variants To Metabolize Ibrutinib In Vitro

Effect of recombinant CYP3A4 variants and interaction on imatinib metabolism in vitro

Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects

Functional Measurement Of Cyp2c9 And Cyp3a4 Allelic Polymorphism On Sildenafil Metabolism

Evaluation of the Effects of 18 Non-Synonymous Single-Nucleotide Polymorphisms of CYP450 2C19 on in Vitro Drug Inhibition Potential by a Fluorescence-Based High-Throughput Assay.

Effects of 22 Novel CYP2D6 Variants Found in the Chinese Population on the Bufuralol and Dextromethorphan Metabolisms in Vitro

Functional Characterization of 27 CYP3A4 Protein Variants to Metabolize Regorafenib In Vitro.

Identification and drug metabolic characterization of four new CYP2C9 variants CYP2C972-75 in the Chinese Han population